These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [A dialysis system with regeneration and recirculation of the dialyzing fluid. In vitro tests of the regeneration of the dialyzing fluid of the artificial kidney and the peritoneal dialysis]. Jutzler GA Ann Univ Sarav Med; 1968; 15(1):1-127. PubMed ID: 5713077 [No Abstract] [Full Text] [Related]
25. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Van Biesen W; Verbeke F; Vanholder R Nephrol Dial Transplant; 2007 Jan; 22(1):53-8. PubMed ID: 17050633 [No Abstract] [Full Text] [Related]
26. Membranes for blood purification: state of the art and new developments. Strathmann H; Göhl H Contrib Nephrol; 1990; 78():119-40; discussion 140-1. PubMed ID: 2225829 [No Abstract] [Full Text] [Related]
27. [The reverse osmosis. The new method of water purification for medical purposes (author's transl)]. Kubiak Z Przegl Lek; 1980; 37(7):579-84. PubMed ID: 7414010 [No Abstract] [Full Text] [Related]
28. [Hemofiltration]. Luciak M; Zbróg Z Pol Tyg Lek; 1982 Jun; 37(16):463-5. PubMed ID: 7134057 [No Abstract] [Full Text] [Related]
29. Purification and concentration by ultrafiltration. Schratter P Methods Mol Biol; 1996; 59():115-34. PubMed ID: 8798192 [No Abstract] [Full Text] [Related]
31. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis. Segall L; Covic A Nephrol Dial Transplant; 2007 Jan; 22(1):59-63. PubMed ID: 17099221 [No Abstract] [Full Text] [Related]
32. [Blood detoxication procedures in extra-renal diseases]. Korten G; Klinkmann H Z Gesamte Inn Med; 1980 Aug; 35(16):suppl 52-5. PubMed ID: 7467574 [TBL] [Abstract][Full Text] [Related]
33. [Regulatory factors for changing laboratory data before and after dialysis therapy]. Doi T Rinsho Byori; 2001 Mar; 49(3):227-30. PubMed ID: 11307319 [TBL] [Abstract][Full Text] [Related]
34. Increased risk of malignancy and blood-membrane interactions in uraemic patients. Akizawa T; Kinugasa E; Koshikawa S Nephrol Dial Transplant; 1994; 9 Suppl 2():162-4. PubMed ID: 8065609 [No Abstract] [Full Text] [Related]
35. Plasma fibronectin concentrations in hemodialyzed patients. Influence of different dialyzers. Schena FP; Pertosa G; Pastore A; Manno C; Pastore G Life Support Syst; 1985; 3(1):83-5. PubMed ID: 3990357 [No Abstract] [Full Text] [Related]
36. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009? Chazot C J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991 [TBL] [Abstract][Full Text] [Related]